Perspective Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Okay, we'll continue with the next session. I'm Paul Choi, and I cover the SMID cap biotech sector here at the firm. It's my pleasure to have Perspective here on stage with us. And what we'll maybe do is what we've done in the previous sessions, and I'll kick it off maybe with some high-level comments, if you will, on just sort of what your strategic priorities are for the remainder of the year and going into '27, and then we'll go into questions.
Terrific. Thanks, Paul, and thanks to Goldman Sachs for hosting us here. So Thijs Spoor, I'm the CEO of Perspective Therapeutics. I have to say this has been an absolutely extraordinary year for us. We're doing an amazing job at pretty consistent execution. And when I say pretty consistent, we're regularly treating patients around the world.
In the US, we regularly enroll in our clinical trials. We're building out our manufacturing network. We have a great cadence for bringing in best-in-class,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
